Acorda Therapeutics Inc.

12/08/2024 | Press release | Distributed by Public on 13/08/2024 10:03

Notice of Effectiveness - Form EFFECT

Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 12, 2024
Accession Number: 0000950170-24-094678
Submission Type: POS AM
CIK: 0001008848
Company Name: Acorda Therapeutics, Inc.
File Number: 333-239519